Poland· PL-100040953
Marvelon
A desogestrel and ethinylestradiol product containing desogestrelum + ethinylestradiolum, registered in Poland by Organon Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Desogestrel and ethinylestradiol is registered in 11 of 19 countries.
Countries holding a registration under ATC G03AA09 (desogestrel and ethinylestradiol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Desogestrel and ethinylestradiol · ATC G03AA09
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Desogestrelum + Ethinylestradiolum
- Manufacturer
- Organon Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G03AA09
- ATC class
- Desogestrel and ethinylestradiol
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990157617
- gtin05909990157624
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
494 interactions on record for desogestrel and ethinylestradiol.
Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Desogestrel and ethinylestradiol · interactions on record
494 records
- 40 severe
- 372 moderate
- 49 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- HeminB06AB01severe
- BosentanC02KX01severe
- GriseofulvinD01AA08severe
33 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Desogestrel and ethinylestradiol in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADELEHeaton k.s., Praha
- CanadaAPRI 21TEVA CANADA LIMITED
- United KingdomAlenini 150microgram/20microgram tabletsActavis UK Ltd
- FinlandBenidetteActavis Group PTC ehf
- SpainAIDESSIA 0,15 MG/ 0,02 MG COMPRIMIDOS EFGLaboratorios Cinfa S.A.
- NetherlandsBryoronna 28 150/30 microgram, filmomhulde tablettenLaboratorios Leon Farma, S.A.
- GermanyAurodes-Ee 20Eugia Pharma (Malta) Limited
- SwitzerlandDesoren 20, FilmtablettenGedeon Richter (Schweiz) AG
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Desofemine, Desogestrel/Ethinylestradiol Effik
- Belgium · Desogeffik, Desolina 20
- Bulgaria · Марвелон, Регулон
- Cyprus · Gracial
- Czechia · Adele, Gracial
- Germany · Aurodes-Ee 20, Aurodes-Ee 30
- Denmark · Daisynelle, Denise
- Estonia · Novynette, Regulon
- Spain · Aidessia, Bemasive
- Finland · Daisynelle, Mercilon
- France · Desobel, Desogestrel / Ethinylestradiol Viatris
- United Kingdom (Northern Ireland) · Bimizza, Cimizt
- Greece · Gracial, Laurina
- Croatia · Novynette
- Hungary · Gracial, Laurina
- Ireland · Gedarel, Gedarel Extra
- Iceland · Mercilon
- Italy · Gracial, Lucille
- Lithuania · Desogestrel/Ethinylestradiol Adalvo, Novynette
- Luxembourg · Desolina 20, Desolina 30
- Latvia · Novynette, Regulon
- Malta · Adele, Mercilon
- Netherlands · Desogestrel/Ethinylestradiol Eugia, Desogestrel/Ethinylestradiol Xiromed
- Portugal · Desogestrel + Etinilestradiol Stallpharma, Destrel
- Romania · Laurina, Marvelon 21
- Sweden · Desolett
- Slovakia · Adele, Mercilon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/44790a1d-132e-48ff-928b-4226fec7fae6 GET /v1/drugs/44790a1d-132e-48ff-928b-4226fec7fae6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "0,15 mg + 0,03 mg",
"packaging": "05909990157617 ¦ Rp ¦ 6293\n21 tabl.\n05909990157624 ¦ Rp ¦ 6294\n63 tabl.",
"substance": "Desogestrelum 150 mcg + Ethinylestradiolum ad 1 ml",
"common_name": "Desogestrelum + Ethinylestradiolum",
"pl_product_id": "100040953",
"pozwolenie_nr": "01576",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about desogestrel and ethinylestradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.